FEI SUN,LING YANG,RUI ZHAO,YILONG ZHOU,YINGHU HU,ZHAOZHONG DING,ZHENG WANG
申请号:
BR112018015880
公开号:
BR112018015880A2
申请日:
2017.02.04
申请国别(地区):
BR
年份:
2018
代理人:
摘要:
The present invention relates to the crystalline form α of a tl7-2-butoxy-7- (4- (pyrrolidin-1-ylmethyl) -benzyl) -5h-pyrrolo [3,2-d] pyrimidin-4-amine agonist (formula i), a method for preparing crystalline form a, and the use thereof.a presente invenção refere-se a forma cristalina a de um agonista de tlr7 2-butóxi-7-(4-(pirrolidin-1-ilmetil)-benzil)-5h-pirrolo [3,2-d]pirimidin-4-amina (fórmula i), um método para preparar a forma cristalina a, e o uso da mesma.